Evidence map›Paper›PMID 8302839›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1994

Stimulation of endogenous ADP-ribosylation by brefeldin A.

M A De Matteis, M Di Girolamo, A Colanzi, M Pallas, G Di Tullio, L J McDonald, J Moss, G Santini, S Bannykh, D Corda

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Components of the CtBP1/BARS-dependent fission machinery.Histochemistry and cell biology · 2013
    Review
  7. Molecular mechanism and functional role of brefeldin A-mediated ADP-ribosylation of CtBP1/BARS.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Trichome morphogenesis: a cell-cycle perspective.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2002
    Review
  13. Article
  14. Article
  15. Structural basis for the inhibitory effect of brefeldin A on guanine nucleotide-exchange proteins for ADP-ribosylation factors.Proceedings of the National Academy of Sciences of the United States of America · 1999
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

M A De MatteisUnit of Physiopathology of Secretion, Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, S. Maria Imbaro (Chieti), Italy.
M Di Girolamo
A Colanzi
M Pallas
G Di Tullio
L J McDonald
J Moss
G Santini
S Bannykh
D Corda
Mario Negri Institute for Pharmacological Research · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brefeldin A (BFA) is a fungal metabolite that exerts profound and generally inhibitory actions on membrane transport. At least some of the BFA effects are due to inhibition of the GDP-GTP exchange on the ADP-ribosylation factor (ARF) catalyzed by membrane protein(s). ARF activation is likely to be a key event in the association of non-clathrin coat components, including ARF itself, onto transport organelles. ARF, in addition to participating in membrane transport, is known to function as a cofactor in the enzymatic activity of cholera toxin, a bacterial ADP-ribosyltransferase. In this study we have examined whether BFA, in addition to inhibiting membrane transport, might affect endogenous ADP-ribosylation in eukaryotic cells. Two cytosolic proteins of 38 and 50 kDa were enzymatically ADP-ribosylated in the presence of BFA in cellular extracts. The 38-kDa substrate was tentatively identified as the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase. The BFA-binding components mediating inhibition of membrane traffic and stimulation of ADP-ribosylation appear to have the same ligand specificity. These data demonstrate the existence of a BFA-sensitive mono(ADP-ribosyl)transferase that may play a role in membrane movements.

Indexed as

Adenosine Diphosphate RiboseADP Ribose TransferasesADP-Ribosylation FactorsAnimalsBiological Transport, ActiveBrefeldin ACell LineCyclopentanesGlyceraldehyde-3-Phosphate DehydrogenasesGTP-Binding ProteinsMycotoxinsNADPoly(ADP-ribose) PolymerasesProteinsRatsSubstrate SpecificityAdenosine Diphosphate RiboseADP Ribose TransferasesADP-Ribosylation FactorsBrefeldin ACyclopentanesGlyceraldehyde-3-Phosphate DehydrogenasesGTP-Binding ProteinsMycotoxinsNADPoly(ADP-ribose) PolymerasesProteins

Identifiers

PMID8302839
PMCPMC521464
OpenAlexW2132703810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.